Recruiting NA INTERVENTIONAL 1-arm
NCT07191106
Pilot Study Assessing the Feasibility and Impact of a Remote Adapted Physical Activity Program on Quality of Life in Patients With Inflammatory Bowel Disease (IBD) (APIMICI)
Pilot Feasibility and Impact Study of a Remote Adapted Physical Activity Program on the Quality of Life of Patients With Inflammatory Bowel Disease (IBD)
Sponsor: Janssen Cilag S.A.S.
Conditions
Inflammatory Bowel Disease (Crohn&Amp;#39;s Disease and Ulcerative Colitis) Inflammatory Bowel Disease (IBD)
Interventions
adapted physical activity
Updated 1 time since 2025 Last updated: Sep 22, 2025 Started: Sep 15, 2025 Primary completion: Oct 30, 2025 Completion: Mar 31, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A NA clinical study on Inflammatory Bowel Disease (Crohn&Amp;#39;s Disease and Ulcerative Colitis) and Inflammatory Bowel Disease (IBD), this trial is actively recruiting participants. The trial is conducted by Janssen Cilag S.A.S. and has accumulated 1 data snapshot since 2025. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
1 version recorded Recruiting — NA
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Janssen Cilag S.A.S.
- Raincy Montfermeil Hospital Group
Data source: Raincy Montfermeil Hospital Group
For direct contact, visit the study record on ClinicalTrials.gov .